Specifically, a study of zibotentan, a highly selective endothelin A ERA, in combination with dapagliflozin in participants with type 2 diabetes (NCT05570305) is currently underway, with similar phase 2 trials in type 1 diabetes being proposed
Food & Drug Administration announced on October 2, 2024, that the shortage of tirzepatide injection has been resolved
Under section 503B of the Federal Food, Drug, and Cosmetic Act, large outsourcing facilities may only compound from bulk active ingredients in two situations: the ingredient appears on the 503B bulks list, meaning FDA has found a clinical need for it, or the finished drug sits on FDA's shortage list at the time of compounding
Self-pay options are commonly available
Seek urgent help if you experience these symptoms and discuss whether to continue treatment with your prescriber
One such study found that glutathione levels increased when vitamin D deficiency was corrected among children with nutritional rickets